• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26921
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/17/2023
Event Type  malfunction  
Event Description
It was reported that the stent partially deployed.An innova 6 x 150 x 130 stent was selected for use in the interventional recanalization procedure to treat an arterial occlusion in the lower extremity.The target lesion was located in the superficial femoral artery (sfa).When the innova delivery system was advanced to the sfa and deployment was attempted, the stent only deployed halfway before becoming stuck.The innova was unable to release fully.The entire system was removed.The procedure was completed using a different device and the patient was reported to be stable.
 
Manufacturer Narrative
Device analysis: returned product consisted of an innova self-expanding stent system.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone and a kink to the inner liner, 16.2cm from the tip.The nosecone was damaged, and a portion was broken off and missing.The nosecone portion of the handle was separated.Microscopic examination revealed no additional damages.The stent appeared to have been deployed and was not returned for analysis.Because there was no evidence of any product quality deficiencies, it was considered likely that the kinked inner liner was attributable to handling after the procedure.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis found damage to the device that could have contributed to the reported event.
 
Event Description
It was reported that the stent partially deployed.An innova 6 x 150 x 130 stent was selected for use in the interventional recanalization procedure to treat an arterial occlusion in the lower extremity.The target lesion was located in the superficial femoral artery (sfa).When the innova delivery system was advanced to the sfa and deployment was attempted, the stent only deployed halfway before becoming stuck.The innova was unable to release fully.The entire system was removed.The procedure was completed using a different device and the patient was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key16991460
MDR Text Key315830731
Report Number2124215-2023-24880
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26921
Device Catalogue Number26921
Device Lot Number0029036514
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/22/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/08/2023
Initial Date FDA Received05/24/2023
Supplement Dates Manufacturer Received06/01/2023
Supplement Dates FDA Received06/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age86 YR
Patient SexFemale
Patient Weight55 KG
-
-